CAS RN: 4313-57-9
1-Methyl-1,4-cyclohexadiene
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20260319
250mg / 1ml / 1g / 5g
Confirm by inquiry
Shanghai, Chongqing 8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 4313-57-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
4313-57-9 / 1-methylcyclohexa-1,4-diene
Standard CAS: 4313-57-9
Multi CAS: Yes
Basic Information
copy
CAS
4313-57-9 copy
Multi CAS
Yes copy
Molecular Formula
C7H10 copy
Molecular Weight
94.150000 copy
Exact Mass
94.078250 copy
InChI
InChI=1S/C7H10/c1-7-5-3-2-4-6-7/h2-3,6H,4-5H2,1H3 copy
InChIKey
QDXQAOGNBCOEQX-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
7 copy
Fraction Csp3
0.43 copy
Molar refractivity
32.13 copy
TPSA
0.0000 copy
LogP / Solubility
WLOGP
2.28 copy
MLOGP
2 copy
XLogP3
2.1 copy
Consensus LogP
2.13 copy
Log S (ESOL)
-1.86 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.98 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-2.17 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.67 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy